Geistlich appoints Diego Gabathuler as new CEO

Dr Andreas Geistlich, who is chairman of the board of directors and served as interim CEO over the past few months, wished the incoming CEO a successful start, saying: “The Geistlich strategic plan includes further investment in new products, solutions and technologies in order to apply regenerative medicine in helping even more people around the world. We are convinced that Diego Gabathuler’s expertise will support us significantly in this mission.”

Geistlich specialises in the regeneration of bone, cartilage and tissue. The company has more than 800 employees worldwide as well as 13 affiliates and 60 distribution partners, through which Geistlich’s medical devices and medicinal products reach around 90 markets worldwide.

In 2019, Gabathuler took over as CEO of Ivoclar from Robert Ganley, who had been Ivoclar’s CEO for 16 years. Under Gabathuler’s leadership, the company achieved excellent operating results in the 2019 and 2021 fiscal years and the highest revenue in its history in 2022. He left Ivoclar in March this year in order to pursue career options outside of the dental industry. Earlier in his career, he held management positions at international digital technology companies such as Logitech, Activision and Electronic Arts.

Tags: